Form D · Other Investment Fund

BioPharma Secured Debt Fund II, S. ar. l.

Luxembourg, N4 · CIK 0001515608

Offering snapshot reported Mar 18, 2011 · SEC filing

Reported sold
$184M
Indefinite offering
Investors reported
12
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Mar 4, 2011
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 18, 2011Initial$184,050,000No comparison12SEC filing
Mar 18, 2011Initial$184,050,000No comparison12SEC filing

Offering details

Securities
Pooled investment fund
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-157019

Source: Form D, filed Mar 18, 2011. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

BIOPHARMA SECURED INVESTMENTS II, SARL

Investment adviser: PHARMAKON ADVISORS, LP

Gross asset value
$138M
Beneficial owners
51
ADV minimum commitment
$0

Reported in Form ADV on Jun 13, 2017. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator INTERTRUST LUXEMBOURG L-2453 LUXEMBOURG, Luxembourg Investor statements: Some (provided to some but not all investors) Related to adviser: No
Auditor ERNST & YOUNG LLP DUBLIN, Ireland
Custodian BANK OF AMERICA DALLAS, Texas, United States Related to adviser: No
Custodian THE ROYAL BANK OF SCOTLAND L-1012 LUXEMBOURG, Luxembourg Related to adviser: No
Marketer GROTON SECURITIES LLC NEW YORK, New York, United States Related to adviser: No
Marketer VIER KLEEBLATT INVESTMENT AG ZURICH, Switzerland Related to adviser: No
Provider details
Annual audit
Yes
Prime brokers
No
Custodians
Yes
Administrator other than the adviser
Yes
External marketing
Yes

GROTON SECURITIES LLC
CRD 126600 · SEC 8-65896

Filing source

Form ADV 1113667 · Jun 13, 2017 · Schedule D 7.B.(1), fund 805-3130153519

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
David Catala Executive
Pierre Claudel Executive
Hugo Froment Executive

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:
65 Boulevard Grande Duchesse Charlotte
Luxembourg, N4, L1331